HB

Hercules Bioventure Partners

North America, California, United States, Saratoga

Description

Hercules Bioventure Partners, a California-based venture capital firm, serves customers across the United States.

Investor Profile

Hercules Bioventure Partners has backed more than 6 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 17% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Post Ipo Equity, Series B rounds (top funding stages).
  • Majority of deals are located in United States, Switzerland.
  • Strong thematic focus on Biotechnology, Pharmaceutical, Biopharma.

Stage Focus

  • Series A (50%)
  • Post Ipo Equity (33%)
  • Series B (17%)

Country Focus

  • United States (67%)
  • Switzerland (33%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Biopharma
  • Health Care
  • Medical
  • Oncology
  • Therapeutics
  • Health Diagnostics
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Hercules Bioventure Partners frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 1
Atheneos Ventures
North America, California, United States, Santa Clara
Co-Investments: 2
AB
North America, Ohio, United States, Cincinnati
Co-Investments: 1
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 1
CDIB Capital
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
CT
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 1
DCI Partners
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1

Which angels does Hercules Bioventure Partners often collaborate with?

LH
North America, California, United States
Shared Deals: 1

What are some of recent deals done by Hercules Bioventure Partners?

Apeximmune Therapeutics

Burlingame, California, United States

Apeximmune Therapeutics engages in the discovery and development of novel biologics that modulate the immune system.

BiotechnologyHealth DiagnosticsLife Science
Series AMar 31, 2025
Amount Raised: $21,300,000
BlossomHill Therapeutics

San Diego, California, United States

BlossomHill Therapeutics, Inc. is a biopharmaceutical company focusing on oncology and autoimmune disorders.

BiopharmaBiotechnologyHealth CareOncologyPharmaceuticalTherapeutics
Series AMar 3, 2021
Amount Raised: $71,000,000
Addex Therapeutics

Plan-les-ouates, Geneve, Switzerland

Addex Therapeutics is a biopharmaceutical company that discovers and develops allosteric modulators for human health.

BiotechnologyHealth CareMedicalPharmaceutical
Post Ipo EquityFeb 28, 2017
Amount Raised: $2,980,229
Addex Therapeutics

Plan-les-ouates, Geneve, Switzerland

Addex Therapeutics is a biopharmaceutical company that discovers and develops allosteric modulators for human health.

BiotechnologyHealth CareMedicalPharmaceutical
Post Ipo EquityMar 9, 2015
Amount Raised: $2,839,906
Armetheon

Menlo Park, California, United States

Armetheon is a cardiovascular focused late-clinical stage specialty pharmaceutical company.

BiopharmaBiotechnologyPharmaceutical
Series BFeb 5, 2015
Amount Raised: $24,300,000
Armetheon

Menlo Park, California, United States

Armetheon is a cardiovascular focused late-clinical stage specialty pharmaceutical company.

BiopharmaBiotechnologyPharmaceutical
Series AAug 28, 2014
Amount Raised: $7,000,000